Association between the direct two-site apoA-I assays and both the presence of atherosclerosis (Table 3A; Supplementary Table S3A) and obstructive CAD (Table 3B; Supplementary Table S3B) was determined in the overall study population and separately in individuals using LLM and not using LLM using models. The gene discussed is APOA1; the disease is atherosclerosis.